Why the presence of an increase in CD4+ T-lymphocyte infiltrate would be associated with poor cancer specific survival in patients with prostate cancer is unclear since it would seem logical that an increased T-lymphocyte infiltrate would help control and even destroy tumour cells. This evidence concerns the gene CD4 and prostate carcinoma.